Table 3.
Overview of Brief Motivational Intervention-Medication Therapy Management
| Interventionist/ education |
Overarching Intervention Component |
Session Content |
|---|---|---|
| PharmD level pharmacist | Medication Therapy Management | Reviewing the opioid medication(s) being taken |
| Discussing misuse screening results | ||
| Exploring behaviors indicative of misuse (e.g., early refills, taking medications too often/higher dosages than prescribed) | ||
| Identifying/documenting possible targets for adherence improvement. | ||
| Brief Motivational Intervention | Facilitating a non-directive discussion regarding motivation to change | |
| Discussing importance/confidence to avoid misuse | ||
| Assisting to resolve ambivalence towards eliminating misuse, and, if appropriate | ||
| Referring to treatment, including but not limited to referral to Patient Navigation | ||
| Master’s level navigator | Patient Navigation and naloxone referral | Session 1: development of therapeutic alliance/rapport and goal setting. |
| Sessions 2–3: identifying barriers and problem resolutions. | ||
| Session 4: reviewing overdose prevention tool-kit and referring/directing to a naloxone prescription/training. | ||
| Sessions 5–7: encouraging and reinforcing treatment adherence, reviewing and identifying other care needs, and offering linkages to service providers as applicable. | ||
| Session8: examines continued challenges to self-care and goals and formulates plans to continue progress |